MITT 2025

Website: https://www.termoablazionetiroide.it/

Minimally Invasive Thyroid Treatments (MITT) have emerged as a pivotal approach in managing both benign and malignant thyroid conditions. Since its foundation in 2018, the MITT group has fostered a multidisciplinary collaboration among medical professionals with diverse expertise, all sharing a commitment to advancing the clinical, diagnostic, and therapeutic management of thyroid and parathyroid diseases.

In preparation for the 2025 MITT meeting, a dedicated morning session on thyroid ultrasound techniques will provide an in-depth exploration of the essential aspects of ultrasound examination and interpretation, integral to the effective application of MITT.

The meeting will feature a comprehensive overview of the latest guidelines for managing benign and malignant thyroid diseases, as well as presentations on the most widely adopted ablation technologies. Cutting-edge evidence supporting the application of MITT in various thyroid conditions will also be discussed. Real-life clinical cases will be analyzed in collaboration with an expert panel, enabling an exchange of insights on practical scenarios.

Hands-on workshops, available throughout the event and concluding the second day, will allow participants to familiarize themselves with the latest technologies and techniques using dedicated phantoms, further enhancing the understanding of MITT applications.

This meeting highlights the continuous evolution and multidisciplinary nature of MITT, showcasing its critical role in advancing thyroid care.